Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
NCT07368361

Th Study Wants to Compare the Best Technique for Sinus Operation in CRSWNP

Led by Kafrelsheikh University · Updated on 2026-01-26

40

Participants Needed

1

Research Sites

34 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This randomized controlled trial aims to compare the efficacy and safety of reboot surgery versus conventional full house FESS in patients with refractory CRSwNP, focusing on: 1\. Primary Outcome: * Compare 24-month recurrence rates (defined as endoscopic polyp score ≥2) 2. Secondary Outcomes: * Recurrence-free survival (time to first recurrence), Quality of life improvement (SNOT-22 scores), Reduction in systemic corticosteroid use, Complication rates (synechiae, bleeding, infection) and Cost-effectiveness of each approach

CONDITIONS

Official Title

Th Study Wants to Compare the Best Technique for Sinus Operation in CRSWNP

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 18 to 75 years
  • Recurrent refractory chronic rhinosinusitis with nasal polyps (CRSwNP) not improved after at least one biologic or prior FESS surgery
  • Confirmed type-2 inflammation endotype by blood or tissue eosinophilia or IgE 7100 IU/mL
  • Lund-Mackay CT score of 10 or higher
Not Eligible

You will not qualify if you...

  • Eosinophilic granulomatosis with polyangiitis (EGPA) or severe systemic diseases except controlled asthma or NSAID-exacerbated respiratory disease
  • Presence of neoplasms
  • Dependence on vasoconstrictor drugs such as oxymetazoline
  • Unilateral nasal inflammatory disease
  • Bilateral inflammatory disease without polyps
  • Treatment with monoclonal antibodies in the past 12 months
  • Patients younger than 18 years
  • Patients unfit for general anesthesia

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Kafrelsheikh Faculty of Medicine

Egypt, Kafrelsheikh, Canada, 33155.

Actively Recruiting

Loading map...

Research Team

A

Amr Maher Shady Kafr Elsheikh Hospital University, Doctor

CONTACT

S

Saad Elzayat Kafr Elsheikh Hospital University, professor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here